HIV/AIDS Therapy
Highly active antiretroviral therapy raised visfatin and RBP-4 and lowered adiponectin in HIV
Published in AIDS Weekly, October 9th, 2006
Researchers publishing in the European Journal of Clinical Investigation recently conducted a study, "To determine circulating levels of adipocytokines, especially the recently characterized visfatin, and the fat-derived factor retinol-binding protein-4 (RBP-4) in HIV-infected subjects and their respective changes following treatment with highly active antiretroviral therapy (HAART)."
"Fourteen HIV-positive, HAART-naive subjects were compared with 10 HIV-negative...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-10-09)
More Articles from AIDS Weekly
- HIV/AIDS Epidemiology
HIV drug-resistant and nonsubtype B strains increasingly common in perinatally infected - HIV/AIDS Pathogenesis
Protection against X4-tropic HIV-1 superinfection involves CD4 HIV-1 Nef mechanisms - HIV/AIDS Prognostics
Time from HIV-1 seroconversion to CD4/CD8 ratio inversion predicts time to AIDS - HIV/AIDS Therapy
Interleukin-2 reconstitutes defective HIV- and CMV-specific CD8+ cell proliferation in HIV/AIDS - HIV/AIDS Transmission
Breastfeeding plus zidovudine reduces mortality rate at 7 months compared with formula feeding - Antifungals
Combination antifungal therapy valuable in pre-emptive management of high-risk patients - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
